Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1879results about How to "Sufficient amount" patented technology

Method and apparatus for obtaining blood for diagnostic tests

Method and apparatus for obtaining a sample of blood from a patient for subsequent diagnostic tests, e.g., glucose monitoring. In one aspect of the invention, the method comprises the steps of:
    • (a) placing a blood collection device over a region on the surface of the skin from which said sample is to be obtained,
    • (b) forming a seal between said blood collection device and said surface of the skin,
    • (c) creating a vacuum sufficient to result in said surface of the skin becoming stretched and engorged with blood,
    • (d) triggering a lancing assembly and causing a lancet to penetrate said skin,
    • (e) retracting said lancet,
    • (f) withdrawing blood toward and onto a fluid collector, and
    • (g) releasing the vacuum.
In another aspect of the invention, an apparatus for carrying out the method described previously is provided. The apparatus comprises:
    • (a) a housing having a sealable chamber located therein and a sealable opening in fluid communication with said sealable chamber,
    • (b) a power source,
    • (c) a vacuum pump operably connected to said power source, said vacuum pump in communication with said sealable chamber,
    • (d) a lancing assembly positioned within said housing, said lancing assembly capable of moving a lancet towards said sealable opening, and
    • (e) a fluid collector positioned in said sealable chamber, said fluid collector in fluid communication with said sealable opening.
Owner:ABBOTT LAB INC

Pd-1 binding proteins

The present invention features PD-1 binding proteins, a subset of which inhibits binding of PD-L1 to the PD-1 receptor. These binding proteins can be employed to modulate the immune system through the manipulation of the PD-1 signaling pathway, enhancing host immunity to treat infections and cancer.
Owner:MERCK SHARP & DOHME LLC

Systems and methods for treatment of coronary artery disease

InactiveUS7481759B2Avoid the needFree the patient from reliance on RFElectrotherapyElectrocardiographyAtrial cavityArterial disease
Methods and systems for treatment of coronary artery disease (CAD) include implantation of the discharge portion(s) of a catheter and, optionally, electrodes on a lead, near the tissue(s) to be stimulated. Stimulation pulses, i.e., drug infusion pulses and optional electrical pulses, are supplied by a stimulator implanted remotely, and through the catheter or lead, which is tunneled subcutaneously between the stimulator and stimulation site. Stimulation sites include the coronary arteries, the aorta, the left ventricle, the left atrium, and / or the pulmonary veins, among other locations. Disclosed treatments include drugs used for acute treatment of CAD, for chronic treatment of CAD, to promote angiogenesis, and / or as AGE Crosslink Breakers, among other drugs. For instance, the systems and methods reduce or eliminate the incidence of CAD and related morbidities, improve symptoms resulting from CAD, and / or improve cardiac blood flow, cardiac function, and patient quality of life.
Owner:CARDIAC PACEMAKERS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products